Cancer Center Administration ABSTRACT Under the direction of Steven T. Rosen, MD, the City of Hope Comprehensive Cancer Center (COHCCC) has continued to enhance its administrative team and its functionality through process improvements, staff restructuring, and growth. Associate Director for Administration Matthew Ruchin, MBA oversees COHCCC Administration and sets administrative priorities to facilitate the strategic advancement of collaborative cancer related research. COHCCC Administration assists the Director, Senior Leadership, Program Leadership, Shared Resource Directors, and Members in fulfilling the mission of COHCCC by offering highly effective administrative management, program planning, and centralized services. The administrative unit supports faculty and staff involved with the CCSG and its related activities, recipients of COHCCC pilot grants, and philanthropic funds. Administration continues to seek guidance from internal and external advisors and act strategically to position itself for growth. Administration's specific duties include: 1. Support the advancement of COHCCC's strategic vision through the implementation of the 2014?2019 COHCCC Strategic Plan and integrate recommendations from advisory boards 2. Assure compliance with CCSG reporting requirements and federal regulations 3. Support a fiscally sound organization through the management all funds and accounts 4. Support recruitment efforts for new COHCCC faculty and leaders in close coordination with the Beckman Research Institute and the City of Hope National Medical Center 5. To coordinate internal and external funding opportunities in support of the cultivation of novel research ideas 6. Management and evaluation of Cancer Center Membership 7. Coordination of information technology required for internal and external data reporting 8. Provide relevant data to COHCCC's Senior Leadership team to support appropriate decision making 9. Communicate with COHCCC members on all activities, funding opportunities, and strategies 10. Provide administrative planning to promote and facilitate scientific collaborations and interactions 11. Provide fiscal control and management of Cancer Center accounts ensuring compliance with all COH institutional policies and federal requirements 12. Provide oversight, logistics support and documentation of senior leadership Committees, retreats and programmatic meetings Recent accomplishments of the Administration Team include successful restructure of membership and completion of a new strategic plan. Funding is requested to cover a portion of the salary for these efforts and to cover a portion of the costs for the Cancer Center seminar series.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA033572-37
Application #
9849195
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
37
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Beckman Research Institute/City of Hope
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Gast, Charles E; Silk, Alain D; Zarour, Luai et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4:eaat7828
Salgia, Ravi; Kulkarni, Prakash (2018) The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer. Trends Cancer 4:110-118
Yoon, Sorah; Wu, Xiwei; Armstrong, Brian et al. (2018) An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFR? Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma. Mol Ther Nucleic Acids 14:131-141
Yim, John H; Choi, Audrey H; Li, Arthur X et al. (2018) Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics. Clin Cancer Res :
Wang, Tianyi; Fahrmann, Johannes Francois; Lee, Heehyoung et al. (2018) JAK/STAT3-Regulated Fatty Acid ?-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. Cell Metab 27:136-150.e5
Magilnick, Nathaniel; Boldin, Mark P (2018) Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate. Curr Stem Cell Rep 4:158-165
Yun, Xinwei; Zhang, Keqiang; Wang, Jinhui et al. (2018) Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma. Mol Cancer Res 16:1161-1171
Herrera, Alex F; Rodig, Scott J; Song, Joo Y et al. (2018) Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. Biol Blood Marrow Transplant 24:514-520
Slavin, Thomas P; Banks, Kimberly C; Chudova, Darya et al. (2018) Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing. J Clin Oncol :JCO1800328
Wittenberg, Elaine; Ferrell, Betty; Koczywas, Marianna et al. (2018) Pilot Study of a Communication Coaching Telephone Intervention for Lung Cancer Caregivers. Cancer Nurs 41:506-512

Showing the most recent 10 out of 1396 publications